Medical Device Ethylene Oxide (EtO) Sterilization Validation Masterclass

Everything That Matters in Medical Device EtO Sterilization Validation is a practical two-day masterclass for teams that need to understand, control, and justify Ethylene Oxide (EtO) sterilization throughout the lifecycle of a sterile medical device.

This course is designed for QA/RA professionals, process engineers, R&D, Manufacturing and NPI teams, packaging teams, project managers, and startup teams involved in the development, manufacturing, validation, and release of sterile medical devices.

The course provides a practical understanding of ISO 11135 requirements for EO sterilization validation, including EO process principles, lethality parameters, microbiological challenge, BI and PCD selection, bioburden, SAL, D-value, worst-case rationale, IQ/OQ/PQ, overkill half-cycle approach, routine monitoring, release criteria, EO residuals, change management, and revalidation.

The goal is to help teams understand, justify, and control the EO sterilization process - even when sterilization is performed by an external supplier - and make better professional decisions throughout the lifecycle of a sterile medical device.

Date: 21.12.26 + 22.12.26   |   Time: 09:30-15:00  | Location: Online   

Why This Course Matters

Ethylene Oxide sterilization is one of the key sterilization methods used for sterile medical devices. Yet in many companies, it is still managed as a “black box”: the product is sent to the sterilization supplier, a validation or cycle report is received, the report is filed, and the product continues toward release.

But sterility is not determined only by a “validated” cycle. It is affected by product design, raw materials, bioburden, packaging, load configuration, BI and PCD selection, EO residuals, routine monitoring, release criteria, deviations, and change management.

This course gives teams the practical understanding needed to know what to ask, what to verify, how to interpret validation and cycle records, how to justify decisions, and how to manage EO sterilization with greater professional confidence.

Why Is This Course Important for You?

• >> Could a packaging change affect EO penetration or residuals?
• >> Does a change in raw material, supplier, or load configuration require reassessment or revalidation?
• >> Does the PCD truly represent the most difficult-to-sterilize location?
• >> Can you defend the EO process during an audit, NB review, or regulatory inspection?
• >> Can you release the product with confidence when part of the process is managed by an external supplier?
• >> Can you interpret half-cycle and full-cycle results and understand whether they support the validation rationale?
• >> Do the PCD location, sensor placement, and acceptance criteria support the most difficult-to-sterilize configuration?
• >> Are routine cycle records and monitoring data sufficient to support product release?
• >> Do you know when a change requires assessment, requalification, or full revalidation?

What Will You Gain?

• > A practical understanding of the EO sterilization process - from chemistry and hazards to process stages and key parameters such as gas concentration, temperature, humidity, and exposure time.
• > Understanding why sterilization is a Special Process - and why sterility cannot be proven by final product testing alone.
• > Professional language for validation decision-making - including IQ, OQ, microbiological and physical PQ, routine monitoring, and product release.
• > Understanding of the microbiological challenge - including BI, PCD, bioburden, SAL, D-value, worst-case selection, and justification of the most difficult-to-sterilize location.
• > Tools to understand the impact of product and packaging characteristics - including lumens, mated surfaces, materials, packaging layers, Tyvek, cartons, and pallet configuration.
• > Ability to identify when changes may affect the validity of the sterilization validation - including changes to product, packaging, material, supplier, manufacturing process, load configuration, or manufacturing environment.
• > Understanding of supporting tests - including EO residuals, sterility testing, pyrogen testing, and packaging considerations.
• > Practical understanding of PQ using the overkill half-cycle approach - including MPQ/PPQ, load configuration, fractional cycles, half cycles, full cycles, sensor and PCD placement, and acceptance criteria.
• > Tools to understand routine monitoring and product release - including cycle records, release criteria, nonconformance handling, annual review, requalification triggers, and requalification options.

This Course Is Especially Important If You Are:

• > Developing a new sterile medical device and planning to use EO sterilization.
• > Preparing for your first EO sterilization validation.
• > Transferring a product from development or NPI to routine manufacturing.
• > Working with an external sterilization supplier and wanting to better understand reports, decisions, and risks.
• > Making changes to packaging, raw materials, load configuration, supplier, or manufacturing site.
• > Preparing for an ISO 13485, FDA, or Notified Body audit.
• > Looking to defend BI/PCD selection, worst-case rationale, product family grouping, and revalidation decisions.
• > Required to review, approve, or defend EO validation reports, routine cycle records, release criteria, or revalidation decisions as part of product release, technical documentation, audits, or supplier oversight.

This Course Is Not Only for Sterilization Experts

This course is designed for anyone whose decisions may affect the suitability of a product for EO sterilization: QA/RA, process engineering, R&D, Manufacturing, NPI, packaging, project management, startup teams, and manufacturers of sterile medical devices.

Design decisions, material selection, packaging configuration, load configuration, supplier changes, and manufacturing changes can all affect the ability to sterilize, aerate, monitor, and release the product with confidence.